| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 5 | |
| #2 | United States | 3 | |
| #3 | Australia | 2 | |
| #4 | Canada | 2 | |
| #5 | EPO (European Patent Office) | 1 | |
| #6 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Climate change adaptation technologies | |
| #4 | Peptides | |
| #5 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Schneider Joerg | 10 |
| #2 | Hill Adrian V S | 7 |
| #3 | Mcshane Helen | 5 |
| #4 | Reece William | 5 |
| #5 | Plebanski Magdalena | 5 |
| #6 | Blanchard Tom | 4 |
| #7 | Gilbert Sarah | 4 |
| #8 | Hanke Tomas | 4 |
| #9 | Gilbert Sarah C | 3 |
| #10 | Hill Adrian Vivian Sinton | 3 |
| Publication | Filing date | Title |
|---|---|---|
| GB0325011D0 | HIV Pharmaccines | |
| GB0322637D0 | HIV pharmaccines | |
| GB0322402D0 | HIV pharmaccines | |
| GB0312803D0 | Fowlpox recombinant genome | |
| US2003138454A1 | Vaccination method |